Search research articles
Contact Us
Filters
Showing results (951-960 of 1,171) with videos related to
Page
of 118
Sort By:
Nature Communications
|
October 7, 2025
Human pancreatic α-cell heterogeneity and trajectory inference analyses reveal SMOC1 as a β-cell dedifferentiation gene
Randy B Kang, Miguel Varela, Eunjin Oh, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 23, 2016
Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation: Optimizing 5-Fluorouracil Dosing in Children With Pediatric Ependymoma
V M Daryani, Y T Patel, M Tagen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2001
Pharmacodynamic model of topotecan-induced time course of neutropenia
W C Zamboni, D Z D'Argenio, C F Stewart, et al.
Blood
|
September 19, 2013
Crenolanib is active against models of drug-resistant FLT3-ITD-positive acute myeloid leukemia
Eric I Zimmerman, David C Turner, Jassada Buaboonnam, et al.
Journal of the American Society of Nephrology : JASN
|
April 24, 1999
Expression and role of parathyroid hormone-related protein in human renal proximal tubule cells during recovery from ATP depletion
A García-Ocaña, S C Galbraith, S K Van Why, et al.
The Journal of Clinical Investigation
|
June 1, 1988
Identification of transcripts encoding a parathyroid hormone-like peptide in messenger RNAs from a variety of human and animal tumors associated with humoral hypercalcemia of malignancy
K Ikeda, M Mangin, B E Dreyer, et al.
JCI Insight
|
December 11, 2019
Pharmacologic and genetic approaches define human pancreatic β cell mitogenic targets of DYRK1A inhibitors
Courtney Ackeifi, Ethan Swartz, Kunal Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2002
Altered irinotecan pharmacokinetics in pediatric high-grade glioma patients receiving enzyme-inducing anticonvulsant therapy
Kristine R Crews, Clinton F Stewart, Dana Jones-Wallace, et al.
Nature Medicine
|
March 10, 2015
A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication
Peng Wang, Juan-Carlos Alvarez-Perez, Dan P Felsenfeld, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
May 6, 2011
A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover
Mara J Horwitz, Mary Beth Tedesco, Susan M Sereika, et al.
Page
of 118
Search research articles
Search
Showing results (951-960 of 1,171) with videos related to
Sort By:
Page
of 118
Nature Communications
|
October 7, 2025
Human pancreatic α-cell heterogeneity and trajectory inference analyses reveal SMOC1 as a β-cell dedifferentiation gene
Randy B Kang, Miguel Varela, Eunjin Oh, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 23, 2016
Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation: Optimizing 5-Fluorouracil Dosing in Children With Pediatric Ependymoma
V M Daryani, Y T Patel, M Tagen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2001
Pharmacodynamic model of topotecan-induced time course of neutropenia
W C Zamboni, D Z D'Argenio, C F Stewart, et al.
Blood
|
September 19, 2013
Crenolanib is active against models of drug-resistant FLT3-ITD-positive acute myeloid leukemia
Eric I Zimmerman, David C Turner, Jassada Buaboonnam, et al.
Journal of the American Society of Nephrology : JASN
|
April 24, 1999
Expression and role of parathyroid hormone-related protein in human renal proximal tubule cells during recovery from ATP depletion
A García-Ocaña, S C Galbraith, S K Van Why, et al.
The Journal of Clinical Investigation
|
June 1, 1988
Identification of transcripts encoding a parathyroid hormone-like peptide in messenger RNAs from a variety of human and animal tumors associated with humoral hypercalcemia of malignancy
K Ikeda, M Mangin, B E Dreyer, et al.
JCI Insight
|
December 11, 2019
Pharmacologic and genetic approaches define human pancreatic β cell mitogenic targets of DYRK1A inhibitors
Courtney Ackeifi, Ethan Swartz, Kunal Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2002
Altered irinotecan pharmacokinetics in pediatric high-grade glioma patients receiving enzyme-inducing anticonvulsant therapy
Kristine R Crews, Clinton F Stewart, Dana Jones-Wallace, et al.
Nature Medicine
|
March 10, 2015
A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication
Peng Wang, Juan-Carlos Alvarez-Perez, Dan P Felsenfeld, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
May 6, 2011
A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover
Mara J Horwitz, Mary Beth Tedesco, Susan M Sereika, et al.
Page
of 118